Cambrex Corp (CBM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBM | RXRX | MAZE | ||
| Company | Cambrex Corp | Recursion Pharmaceuticals Inc Cl A | Maze Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 59.99 | 4.10 | 40.22 | ||
| High | 59.99 | 4.14 | 41.60 | ||
| Low | 59.98 | 4.05 | 39.67 | ||
| Latest | 59.99 | 4.09 | 41.43 | ||
| Change | unch | -0.02 | +1.38 | ||
| % Change | unch | -0.49% | +3.45% | ||
| Volume | 703,100 | 15,217,301 | 397,900 | ||
| 20-Day Average Volume | 282,895 | 23,595,010 | 472,295 | ||
| Previous Close | 59.99 | 4.11 | 40.05 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 59.87 | 4.45 | 40.82 | ||
| 20-Day Raw Stochastic | 100.00% | 3.85% | 68.16% | ||
| 20-Day Relative Strength | 65.76 | 42.35 | 60.76 | ||
| Weighted Alpha | +15.10 | -55.14 | +119.01 | ||
| Today's Opinion | 100% Buy | 100% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Sell | 88% Buy | ||
| Last Month's Opinion | 88% Buy | 88% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.08% since 11/26/19 | -6.19% since 12/23/25 | -2.06% since 12/23/25 | ||
| Low | 59.87 on 11/27/19 | 4.05 on 12/31/25 | 39.58 on 12/30/25 | ||
| High | 59.99 on 12/03/19 | 4.43 on 12/24/25 | 42.92 on 12/24/25 | ||
| 1-Month | |||||
| %Chg | +0.32% since 11/01/19 | -11.66% since 11/28/25 | +9.75% since 11/28/25 | ||
| Low | 59.72 on 11/04/19 | 4.05 on 12/31/25 | 36.84 on 12/02/25 | ||
| High | 59.99 on 12/03/19 | 5.09 on 12/08/25 | 43.29 on 12/04/25 | ||
| 3-Month | |||||
| %Chg | +0.72% since 09/03/19 | -16.19% since 09/30/25 | +59.78% since 09/30/25 | ||
| Low | 59.38 on 10/02/19 | 3.81 on 11/20/25 | 24.99 on 10/02/25 | ||
| High | 60.14 on 09/06/19 | 7.18 on 10/20/25 | 43.29 on 12/04/25 | ||
| 6-Month | |||||
| %Chg | +51.57% since 06/03/19 | -19.17% since 06/30/25 | +237.65% since 06/30/25 | ||
| Low | 39.58 on 08/05/19 | 3.81 on 11/20/25 | 10.98 on 07/03/25 | ||
| High | 60.29 on 08/14/19 | 7.18 on 10/20/25 | 43.29 on 12/04/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,023,102 | 2,126,138 | 1,993,570 | ||
| Shares Outstanding, K | 33,724 | 519,838 | 48,119 | ||
| Annual Sales | 532,090,000 | 58,840,000 | 167,500,000 | ||
| Annual Net Income | 92,420,000 | -463,660,000 | 52,230,000 | ||
| Last Quarter Sales | 148,560,000 | 5,180,000 | 0 | ||
| Last Quarter Net Income | 9,550,000 | -162,250,000 | -30,090,000 | ||
| 60-Month Beta | 2.13 | 0.94 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.31 on 05/02/19 | -0.36 on 11/05/25 | -0.66 on 11/06/25 | ||
| Latest Earnings Date | 02/12/20 | 02/27/26 | 03/30/26 | ||
| Most Recent Dividend | 14.000 on 05/04/07 | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||